Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec Convatec False /oidc-signin/en-us/

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Convatec announces the release of ConvaMax™

Convatec Group Plc (“Convatec”), a leading global medical technology company, announced January 14th 2020 the release of  ConvaMax™  the NEW superabsorber dressing distributed by Convatec. The global superabsorber market is currently greater than $100m growing at +7% 1

ConvaMax™  superabsorber wound dressing is used for the management of highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers and dehisced surgical wounds.

ConvaMax™  superabsorber manages excess moisture to help protect skin integrity2. Where there is a real risk of skin damage due to high levels of exudate, ConvaMax™  is ideal. It is available in non-adhesive and silicone adhesive forms, providing complete flexibility to support your care protocol. This includes under compression bandaging or with an additional primary dressing.

At Convatec, we are committed to innovating our product pipeline providing both our customers and patients with further differentiated technologies and complete solutions for managing chronic and acute wounds. 

David Shepherd, President of Convatec’s Advanced Wound Care Franchise, believes that: “ConvaMax™ will add to our already strong wound portfolio. ConvaMax™ gives us a great product for highly exuding wounds; the reception from our sales and marketing colleagues and the expert customers who have seen the dressings already has been extremely positive, and we look forward to a similar reaction as countries begin to launch the product in the coming months.”

  1. Full year Sales 2018 Smartrak 2019

  2. World Union of Wound Healing Societies (2019) Consensus Document. Wound exudate: effective assessment and management Wounds International. Available at: www.woundsinternational.com

For more information please call.

Enquiries
Analysts and Investors
investorrelations@convatec.com

Mark Reynolds, Director Investor Relations
+44 (0)7551 036625

Media
convatec@buchanan.uk.com

Buchanan Charles Ryland/Chris Lane/Vicky Hayns
+44 (0)207 466 5000

About Convatec
Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. 

Press Release

See all

5/13/2022

Convatec announces the release of ConvaMax™

Read more

5/13/2022

Interim Results for the 6 months ended 30 June 2020

Read more

5/13/2022

Trading update for the three months ended 30 September 2020

Read more

5/13/2022

Expert panel publishes Wound Hygiene consensus

Read more

5/13/2022

Non-Executive Director appointment

Read more

5/13/2022

Convatec Group Plc Annual Results 2019

Read more

5/13/2022

Trading update for the three months ended 31 March 2020

Read more

5/13/2022

Non-Executive Director appointment

Read more

5/13/2022

Board Changes

Read more

5/13/2022

Non-Executive Director appointment

Read more